Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Scancell appoints Eurogentec SCIB1 material manufacturer Scancell has signed an agreement with Eurogentec for the manufacture of new supplies of Scancell’s SCIB1 ImmunoBody vaccine for use in the US clinical study of SCIB1 in combination with a checkpoint inhibitor, expected to commence in 2017.
Production & Manufacturing > Manufacturing > News
Shire acquires stake in Chronos Therapeutics By PBR Staff Writer
Shire has acquired a stake in Chronos Therapeutics, a UK-based privately held biotechnology company focused on diseases of ageing, brain and nervous system disorders.
Production & Manufacturing > Manufacturing > News MilliporeSigma starts work on $115m life science campus in Massachusetts By PBR Staff Writer
MilliporeSigma has started construction on a $115m multi-faceted life science campus in Burlington, Massachusetts, US.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
AstraZeneca, Sandoz resolve Faslodex patent litigation in US
By PBR Staff Writer
AstraZeneca has signed an agreement with Sandoz, the generic pharmaceuticals division of Novartis, to resolve Faslodex (fulvestrant) patent litigation in the US.
Production & Manufacturing > Manufacturing > News
Molnar-Institute: Benefits and Capabilities of DryLab®
| By Molnár-Institute
Anybody working in the realm of HPLC who wishes to economize the resources spent developing and running methods can benefit from the advantages offered by DryLab®.
Production & Manufacturing > Manufacturing > White Papers
DryLab4 Training Course and Quality by Design Principles Course
The Molnár-Institute is pleased to welcome our attendees from around the world to our DryLab4 Training Course and Quality by Design Principles Course this fall, from Monday September 26th to Wednesday, September 28th. The course will be hosted at the Maritim proArte Hotel in central Berlin.
Production & Manufacturing > Manufacturing > Press Releases
Funds advised by Apax Partners agree to buy operating subsidiaries of Invent Farm
By PBR Staff Writer
Funds advised by Apax Partners have agreed to acquire the operating subsidiaries of Spanish pharmaceutical firm Invent Farm from a consortium of investors led by Silfurberg, Framtakssjóður Íslands and Horn II.
Production & Manufacturing > Manufacturing > News
Teligent advances $50m facility expansion in Buena
Teligent has broken ground on the ongoing expansion of its manufacturing and research and development complex in Buena, NJ.
Production & Manufacturing > Manufacturing > News
Aprecia Pharmaceuticals signs $30m debt financing agreement with Hercules Capital
Aprecia Pharmaceuticals, a commercial stage pharmaceutical company developing, manufacturing and marketing fast melt formulations of high dose pharmaceuticals, has entered into an up to $30m debt financing agreement with Hercules Capital.
Production & Manufacturing > Manufacturing > News
AstraZeneca divests two dermatology drug rights to LEO Pharma
By PBR Staff Writer
AstraZeneca has sold the rights to develop tralokinumab drug to treat atopic dermatitis to LEO Pharma.
Production & Manufacturing > Manufacturing > News
Novo Nordisk Pharmatech Now Distributing with Brenntag Specialities
Novo Nordisk Pharmatech A/S and Brenntag Specialties, Inc. (BSI) have entered into a distribution agreement for Pharmaceutical Grade Quaternary Ammonium Compounds into the Pharmaceutical, Over-the-Counter (OTC), and Personal Care Markets in the United States and Puerto Rico.
Production & Manufacturing > Manufacturing > Press Releases
Merck to develop vaccine manufacturing processes with International Vaccine Institute
Merck has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.
Production & Manufacturing > Manufacturing > News
Intensity Therapeutics raises $10m to fund clinical supplies manufacturing and phase I/II trials of INT230-6
Intensity Therapeutics, a privately held biotechnology company developing proprietary cancer immunotherapy products, has secured $10 million in new capital from a Series A preferred stock financing.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests